… A growing level of evidence has emerged showing that the use of extended infusion or
continuous infusion (CI) PIP/TAZ may be more beneficial than standard intermittent 30-min …

… AEs resolved without clinical consequence, and 19 (28%) were ongoing at discharge from
hospital or 30 days following the last extended-infusion dose if the child was still hospitalized. …

… measured by the pre-hospitalization CSHA Clinical Frailty Scale recorded at enrollment) on
the pharmacokinetics of piperacillin/tazobactam [8]. Hospitalized adult patients who had an …

… the population pharmacokinetic models developed for piperacillin-tazobactam and provides
… Simulations showed that continuous or extended infusion methods performed better than …

… based on a total daily piperacillin-tazobactam dose of 24/3, … bolus), 3 h or 4 h (extended
infusion duration equal to half of the … CCU at Severance Cardiovascular Hospital for their routine …

… Hospitalized critically ill adult patients receiving piperacillin-tazobactam (TZP) for a culture-…
Target attainments of greater than 75% were achieved when using extended infusion times of …

… Furthermore, extended infusion seems to be beneficial in certain ICU … At the time when
piperacillin-tazobactam continuous infusion was initiated at the ICU at Aarhus University Hospital, …

… by continuous (CI) or extended infusion over the more traditional intermittent bolus method.
… Hospital, France. Patients admitted to this ICU and receiving piperacillin-tazobactam by CI …

… tertiary referral hospital from September 2020 to April 2021 (Hallym University Sacred
Heart Hospital, Anyang, South Korea). Clinical indications for piperacillin/tazobactam included …

… Administration and sampling methods for piperacillin-tazobactam in the studies included in
this review… Characteristics of the population pharmacokinetics models included in this review. …